Postby Rock_Robster » Mon Nov 29, 2021 9:51 pm
Given it’s the liver, this is most likely to be a highly-targeted form of radiation known as SBRT (or SABR). This has the benefit of (usually) minimal systemic side effects when compared with typical wide-field radiation. A lot of work will go into trying to avoid radiating healthy tissue, which may also include inserting tiny fiducial markers prior to the treatment.
As you point out, fatigue is likely, and some nausea is possible. Most folk seem to tolerate this process well, and local tumour control rates are generally very good.
Best of luck for it!
Rob
41M Australia
2018 Dx RC
G2 EMVI LVI, 4 liver mets
pT3N1aM1a Stage IVa MSS NRAS G13R
CEA 14>2>32>16>19>30>140>70
11/18 FOLFOX
3/19 Liver resection
5/19 Pelvic IMRT
7/19 ULAR
8/19 Liver met
8/19 FOLFOX, FOLFOXIRI, FOLFIRI
12/19 Liver resection
NED 2 years
11/21 Liver met, PALN, lung nodules
3/22 PVE, lymphadenectomy, liver SBRT
10/22 PALN SBRT
11/22 Liver mets, peri nodule. Xeloda+Bev
4/23 XELIRI+Bev
9/23 ATRIUM trial
12/23 Modified FOLFIRI+Bev
3/24 VAXINIA (CF33 + hNIS) trial